• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波士顿认知评估(BOCA)在意大利人群中的效度验证及聚合效度:与蒙特利尔认知评估(MoCA)在阿尔茨海默病谱系中的比较研究

Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum.

作者信息

Padovani Alessandro, Caratozzolo Salvatore, Galli Alice, Crosani Luca, Zampini Silvio, Cosseddu Maura, Turrone Rosanna, Zancanaro Andrea, Gumina Bianca, Vicini-Chilovi Barbara, Benussi Alberto, Vyshedskiy Andrey, Pilotto Andrea

机构信息

Neurology Unit, Department of Clinical and Experimental Sciences, University of Brescia, Brescia, Italy.

Department of continuity of care and frailty, Neurology Unit, ASST Spedali Civili Hospital, Brescia, Italy.

出版信息

Neurol Sci. 2025 Feb;46(2):697-704. doi: 10.1007/s10072-024-07775-3. Epub 2024 Sep 24.

DOI:10.1007/s10072-024-07775-3
PMID:39313687
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11772383/
Abstract

BACKGROUND

The Boston Cognitive Assessment (BOCA) is a self-administered online test developed for cognitive screening and longitudinal monitoring of brain health in an aging population. The study aimed to validate BOCA in an Italian population and to investigate the convergent validity with the Montreal Cognitive Assessment (MOCA) in healthy ageing population and patients within the Alzheimer Disease spectrum.

METHODS

BOCA was administered to 150 participants, including cognitively healthy controls (HC, n = 50), patients with mild cognitive impairment (MCI, n = 50), and dementia (DEM, n = 50). The BOCA reliability was assessed using (i) Spearman's correlation analysis between subscales; (ii) Cronbach's alpha calculation, and (iii) Principal Component Analysis. Repeated-measures ANOVA was employed to assess the impact of the sequence of test administrations between the groups. BOCA performance between HS, MCI and DEM and within different severity subgroups were compared using Kruskall Wallis test. Furthermore, a comparison was conducted between MCI patients who tested positive for amyloid and those who tested negative, utilizing Mann Whitney's U-test.

RESULTS

Test scores were significantly different between patients and controls (p < 0.001) suggesting good discriminative ability. The Cronbach's alpha was 0.82 indicating a good internal consistency of the BOCA subscales and strong-to-moderate Spearman's correlation coefficients between them. BOCA total and subscores differ across different MoCA severity subgroups and demonstrated strong correlation with MoCA scores (rho = 0.790, p < 0.001).

CONCLUSIONS

The Italian version of the BOCA test exhibited validity, feasibility, and accurate discrimination closely performing as MoCA.

摘要

背景

波士顿认知评估(BOCA)是一种用于老年人群认知筛查和脑健康纵向监测的自施式在线测试。本研究旨在验证BOCA在意大利人群中的有效性,并调查其在健康老年人群和阿尔茨海默病谱系患者中与蒙特利尔认知评估(MOCA)的收敛效度。

方法

对150名参与者进行了BOCA测试,包括认知健康对照组(HC,n = 50)、轻度认知障碍患者(MCI,n = 50)和痴呆患者(DEM,n = 50)。使用(i)分量表之间的斯皮尔曼相关性分析;(ii)克朗巴哈α系数计算;以及(iii)主成分分析来评估BOCA的可靠性。采用重复测量方差分析来评估测试施测顺序对各组的影响。使用克鲁斯卡尔 - 沃利斯检验比较HS、MCI和DEM组之间以及不同严重程度亚组内的BOCA表现。此外,利用曼 - 惠特尼U检验对淀粉样蛋白检测呈阳性和阴性的MCI患者进行比较。

结果

患者与对照组之间的测试分数存在显著差异(p < 0.001),表明具有良好的区分能力。克朗巴哈α系数为0.82,表明BOCA分量表具有良好的内部一致性,且它们之间的斯皮尔曼相关系数为强到中度。BOCA总分和分项得分在不同的MoCA严重程度亚组中存在差异,并与MoCA分数显示出强相关性(rho = 0.790,p < 0.001)。

结论

意大利版的BOCA测试表现出有效性、可行性和准确的区分能力,与MoCA表现相近。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5a8/11772383/b51ffc37d428/10072_2024_7775_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5a8/11772383/4d7bef9ad807/10072_2024_7775_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5a8/11772383/b51ffc37d428/10072_2024_7775_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5a8/11772383/4d7bef9ad807/10072_2024_7775_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f5a8/11772383/b51ffc37d428/10072_2024_7775_Fig2_HTML.jpg

相似文献

1
Validation and convergent validity of the Boston cognitive assessment (BOCA) in an Italian population: a comparative study with the Montreal cognitive assessment (MoCA) in Alzheimer's disease spectrum.波士顿认知评估(BOCA)在意大利人群中的效度验证及聚合效度:与蒙特利尔认知评估(MoCA)在阿尔茨海默病谱系中的比较研究
Neurol Sci. 2025 Feb;46(2):697-704. doi: 10.1007/s10072-024-07775-3. Epub 2024 Sep 24.
2
Accuracy and Psychometric Properties of the Brazilian Version of the Montreal Cognitive Assessment as a Brief Screening Tool for Mild Cognitive Impairment and Alzheimer's Disease in the Initial Stages in the Elderly.《蒙特利尔认知评估巴西版作为老年人轻度认知障碍和阿尔茨海默病初始阶段简易筛查工具的准确性和心理测量学特性》
Dement Geriatr Cogn Disord. 2019;47(4-6):366-374. doi: 10.1159/000501308. Epub 2019 Aug 29.
3
Boston cognitive assessment (BOCA) - a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance.波士顿认知评估(BOCA)- 一种全面的、可自我管理的、基于智能手机和计算机的家庭测试,用于纵向跟踪认知表现。
BMC Neurol. 2022 Mar 15;22(1):92. doi: 10.1186/s12883-022-02620-6.
4
Criterion and convergent validity of the Montreal cognitive assessment with screening and standardized neuropsychological testing.蒙特利尔认知评估量表与筛查和标准化神经心理学测试的效标和 convergent 效度。
J Am Geriatr Soc. 2013 Dec;61(12):2181-2185. doi: 10.1111/jgs.12541. Epub 2013 Dec 9.
5
Validation of Montreal Cognitive Assessment and Discriminant Power of Montreal Cognitive Assessment Subtests in Patients With Mild Cognitive Impairment and Alzheimer Dementia in Turkish Population.蒙特利尔认知评估量表在土耳其轻度认知障碍和阿尔茨海默病痴呆患者中的效度验证及蒙特利尔认知评估量表各子测验的鉴别力研究
J Geriatr Psychiatry Neurol. 2014 Jun;27(2):103-9. doi: 10.1177/0891988714522701. Epub 2014 Feb 26.
6
Comparative study of two Chinese versions of Montreal Cognitive Assessment for Screening of Mild Cognitive Impairment.用于筛查轻度认知障碍的两种中文版蒙特利尔认知评估量表的比较研究
Appl Neuropsychol Adult. 2021 Jan-Feb;28(1):88-93. doi: 10.1080/23279095.2019.1602530. Epub 2019 Apr 23.
7
Effects of Normative Adjustments to the Montreal Cognitive Assessment.蒙特利尔认知评估量表的常模调整效应。
Am J Geriatr Psychiatry. 2018 Dec;26(12):1258-1267. doi: 10.1016/j.jagp.2018.09.009. Epub 2018 Sep 21.
8
Relationship between the Montreal Cognitive Assessment and Mini-mental State Examination for assessment of mild cognitive impairment in older adults.蒙特利尔认知评估量表与简易精神状态检查表在评估老年人轻度认知障碍中的关系。
BMC Geriatr. 2015 Sep 7;15:107. doi: 10.1186/s12877-015-0103-3.
9
Validity of the Georgian Montreal Cognitive Assessment for the Screening of Mild Cognitive Impairment and Dementia.格鲁吉亚版蒙特利尔认知评估量表用于筛查轻度认知障碍和痴呆的效度
Am J Alzheimers Dis Other Demen. 2017 Feb;32(1):36-40. doi: 10.1177/1533317516679304. Epub 2016 Dec 19.
10
The Turkish validity and reliability of Addenbrooke's Cognitive Examination III.阿登布鲁克认知功能测试第三版在土耳其的效度和信度
Int J Lang Commun Disord. 2025 Jan-Feb;60(1):e13147. doi: 10.1111/1460-6984.13147.

引用本文的文献

1
A pilot comparison of remote versus in-clinic digital cognitive assessments for older adults in primary care settings.基层医疗环境中针对老年人的远程与门诊数字认知评估的初步比较
medRxiv. 2025 Aug 21:2025.08.19.25333983. doi: 10.1101/2025.08.19.25333983.

本文引用的文献

1
Digital Cognitive Assessment Tests for Older Adults: Systematic Literature Review.老年人数字认知评估测试:系统文献综述
JMIR Ment Health. 2023 Dec 8;10:e47487. doi: 10.2196/47487.
2
Boston cognitive assessment (BOCA) - a comprehensive self-administered smartphone- and computer-based at-home test for longitudinal tracking of cognitive performance.波士顿认知评估(BOCA)- 一种全面的、可自我管理的、基于智能手机和计算机的家庭测试,用于纵向跟踪认知表现。
BMC Neurol. 2022 Mar 15;22(1):92. doi: 10.1186/s12883-022-02620-6.
3
Equating Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA) scores: conversion norms from a healthy Italian population sample.
将简易精神状态检查(MMSE)和蒙特利尔认知评估(MoCA)评分进行等同化:来自健康意大利人群样本的转换规范。
Aging Clin Exp Res. 2022 Jul;34(7):1721-1724. doi: 10.1007/s40520-022-02089-w. Epub 2022 Feb 19.
4
"Real-world" eligibility for aducanumab depends on clinical setting and patients' journey.阿杜卡奴单抗的“真实世界”准入取决于临床环境和患者的治疗历程。
J Am Geriatr Soc. 2022 Feb;70(2):626-628. doi: 10.1111/jgs.17530. Epub 2021 Nov 9.
5
Current advances in digital cognitive assessment for preclinical Alzheimer's disease.临床前阿尔茨海默病数字认知评估的当前进展
Alzheimers Dement (Amst). 2021 Jul 20;13(1):e12217. doi: 10.1002/dad2.12217. eCollection 2021.
6
The Boston cognitive assessment: Psychometric foundations of a self-administered measure of global cognition.波士顿认知评估:一种自我管理的全球认知量表的心理测量学基础。
Clin Neuropsychol. 2022 Nov;36(8):2313-2330. doi: 10.1080/13854046.2021.1933190. Epub 2021 Jun 2.
7
Diminished Learning Over Repeated Exposures (LORE) in preclinical Alzheimer's disease.临床前阿尔茨海默病中重复暴露导致的学习能力下降(LORE)
Alzheimers Dement (Amst). 2021 Jan 5;12(1):e12132. doi: 10.1002/dad2.12132. eCollection 2020.
8
Unsupervised assessment of cognition in the Healthy Brain Project: Implications for web-based registries of individuals at risk for Alzheimer's disease.健康大脑计划中认知的无监督评估:对基于网络的阿尔茨海默病风险个体登记处的启示。
Alzheimers Dement (N Y). 2020 Jun 26;6(1):e12043. doi: 10.1002/trc2.12043. eCollection 2020.
9
Profiles of Cognitive Change in Preclinical and Prodromal Alzheimer's Disease Using Change-Point Analysis.使用变化点分析研究临床前和前驱期阿尔茨海默病的认知变化特征。
J Alzheimers Dis. 2020;75(4):1169-1180. doi: 10.3233/JAD-191268.
10
Digital biomarkers for Alzheimer's disease: the mobile/ wearable devices opportunity.阿尔茨海默病的数字生物标志物:移动/可穿戴设备带来的机遇。
NPJ Digit Med. 2019;2. doi: 10.1038/s41746-019-0084-2. Epub 2019 Feb 21.